세계의 기능 유전체학 시장 - 산업 규모, 점유율, 동향, 기회 및 예측(제품별, 기술별, 용도별, 최종 사용자별, 지역별, 경쟁, 2020-2030년)
Functional Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Application, By End User, By Region and Competition, 2020-2030F
상품코드:1878837
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 기능 유전체학 시장은 2024년에 104억 3,000만 달러로 평가되었으며, 2030년까지 연평균 복합 성장률(CAGR) 9.30%를 나타내 177억 8,000만 달러에 이를 것으로 예측됩니다.
기능 유전체학은 생물체 내의 유전자와 단백질의 기능뿐만 아니라 그들의 상호 작용을 체계적으로 조사하고 생물학적 과정과 표현형의 해명을 도모하는 학문입니다. 시장 확대의 주요 요인은 높은 처리량 시퀀싱 기술의 진보, 유전체 연구 투자 증가, 맞춤형 의료 및 표적 요법에 대한 세계 수요 증가에 있습니다. 게다가 만성 질환과 유전성 질환의 유병률 증가도 고급 유전체 이해와 진단 도구의 필요성을 크게 뒷받침하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
104억 3,000만 달러
시장 규모(2030년)
177억 8,000만 달러
CAGR(2025-2030년)
9.3%
가장 빠르게 성장하는 부문
키트 및 분석
가장 큰 시장
북미
주요 시장 성장 촉진요인
세계의 기능 유전체학 시장은 유전체 시퀀싱의 지속적인 기술 진보에 크게 영향을 받고 있습니다. 이 진보에 의해 유전자 분석의 효율성과 접근 가능성이 끊임없이 향상하고 있습니다. 시퀀싱 플랫폼의 획기적인 진보로 유전체 데이터 생성 비용이 극적으로 줄어들고 속도가 향상됨에 따라 연구자들은 전례없는 규모로 연구를 수행 할 수있었습니다.
주요 시장 과제
세계의 기능 유전체학 시장의 성장을 막는 주요 과제는 전문 기술과 필요한 전문 지식과 관련된 엄청난 양의 초기 투자와 지속적인 운영 비용입니다. 이러한 재정적 부담은 특히 소규모 연구 기관 및 신흥 생명 공학 기업에서 시장의 보급을 직접적으로 제한합니다.
주요 시장 동향
유전체 분석에 대한 인공지능(AI)과 머신러닝의 통합은 세계의 기능 유전체학 시장에서 중요한 동향으로 복잡한 생물학적 데이터의 해석과 활용 방법을 변화시키고 있습니다. 이러한 기술은 전통적인 방법으로 처리할 수 없는 엄청난 데이터 세트를 처리하여 유전자 기능의 식별, 질병 메커니즘의 이해, 치료 표적 발견의 정확성과 속도를 향상시킵니다.
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 기능 유전체학 시장 전망
시장 규모와 예측
금액별
시장 점유율·예측
제품별(키트 및 분석법, 기기)
기술별(차세대 시퀀싱(NGS), 중합효소 연쇄반응(PCR), 마이크로어레이, 기타 기술)
용도별(에피제노믹스, 트랜스크립토믹스, 프로테오믹스, 대사체학)
최종 사용자별(학술 및 연구 기관, 바이오테크놀러지 및 바이오의약품기업, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 기능 유전체학 시장 전망
시장 규모와 예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 기능 유전체학 시장 전망
시장 규모와 예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 기능 유전체학 시장 전망
시장 규모와 예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 기능 유전체학 시장 전망
시장 규모와 예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
남아프리카
제10장 남미의 기능 유전체학 시장 전망
시장 규모와 예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
합병 및 인수
제품 출시
최근 동향
제13장 세계의 기능 유전체학 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation(Integrated DNA Technologies, Inc.)
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
MRM Proteomics Inc
Perkin Elmer, Inc.
QIAGEN NV
Thermo Fisher Scientific, Inc.
제16장 전략적 제안
제17장 기업 소개와 면책사항
KTH
영문 목차
영문목차
The Global Functional Genomics Market, valued at USD 10.43 Billion in 2024, is projected to experience a CAGR of 9.30% to reach USD 17.78 Billion by 2030. Functional genomics involves the systematic investigation of gene and protein functions and their interactions within an organism to elucidate biological processes and phenotypic expression. The market's expansion is fundamentally driven by advancements in high-throughput sequencing technologies, increasing investments in genomic research, and the escalating global demand for personalized medicine and targeted therapies. Furthermore, the growing prevalence of chronic diseases and genetic disorders contributes significantly to the imperative for advanced genomic understanding and diagnostic tools.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 10.43 Billion
Market Size 2030
USD 17.78 Billion
CAGR 2025-2030
9.3%
Fastest Growing Segment
Kits & Assays
Largest Market
North America
Key Market Drivers
The Global Functional Genomics Market is significantly influenced by ongoing technological advancements in genomic sequencing, which continuously enhance the efficiency and accessibility of genetic analysis. Breakthroughs in sequencing platforms have dramatically reduced the cost and increased the speed of generating genomic data, enabling researchers to conduct studies at an unprecedented scale. For instance, according to *Next-Generation Sequencing Costs: The Sub $100 Genome*, in September 2024, Complete Genomics released the DNBSEQ-T20x2 sequencing platform, capable of producing 50,000 whole genome sequences per year for less than $100 per 30x human genome. This reduction makes population-scale functional genomics projects more feasible, fostering a deeper understanding of gene function in health and disease and driving the discovery of new therapeutic targets and biomarkers. The increased throughput allows for more extensive experimental designs, moving beyond single-gene studies to comprehensive functional analyses across entire genomes or transcriptomes.
Key Market Challenges
A significant challenge impeding the growth of the Global Functional Genomics Market is the substantial initial investment and ongoing operational costs associated with its specialized technologies and required expertise. These financial demands directly limit market adoption, particularly among smaller research institutions and emerging biotechnology firms. Such entities frequently lack the extensive capital resources necessary to acquire high-throughput sequencing platforms, establish robust bioinformatics infrastructure, and recruit skilled personnel essential for functional genomics research. This financial barrier restricts overall market expansion by reducing the number of active participants and the volume of genomic studies undertaken globally.
Key Market Trends
The integration of Artificial Intelligence and Machine Learning for genomic analysis represents a significant trend in the Global Functional Genomics Market, transforming how complex biological data is interpreted and utilized. These technologies enhance the precision and speed of identifying gene functions, understanding disease mechanisms, and discovering therapeutic targets by processing vast datasets that would be unmanageable through traditional methods. According to a Pistoia Alliance survey conducted in October 2025, 77% of life sciences laboratories anticipate using AI within the next two years, with AI remaining the top investment area for 63% of respondents for the third consecutive year. This demonstrates a strong industry commitment to leveraging AI for advanced genomic insights.
Key Market Players
Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation (Integrated DNA Technologies, Inc.)
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
MRM Proteomics Inc
Perkin Elmer, Inc.
QIAGEN N.V.
¬¬¬Thermo Fisher Scientific, Inc.
Report Scope:
In this report, the Global Functional Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Functional Genomics Market, By Product:
Kits & Assays
Instruments
Functional Genomics Market, By Technology:
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Microarray
Other Technologies
Functional Genomics Market, By Application:
Epigenomics
Transcriptomics
Proteomics
Metabolomics
Functional Genomics Market, By End-User:
Academic and Research Institutions
Biotechnology and Biopharmaceutical Companies
Others
Functional Genomics Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Functional Genomics Market.
Available Customizations:
Global Functional Genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Functional Genomics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Kits & Assays, Instruments)
5.2.2. By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Other Technologies)
5.2.3. By Application (Epigenomics, Transcriptomics, Proteomics, Metabolomics)
5.2.4. By End-User (Academic and Research Institutions, Biotechnology and Biopharmaceutical Companies, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Functional Genomics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End-User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Functional Genomics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End-User
6.3.2. Canada Functional Genomics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End-User
6.3.3. Mexico Functional Genomics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End-User
7. Europe Functional Genomics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End-User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Functional Genomics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End-User
7.3.2. France Functional Genomics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End-User
7.3.3. United Kingdom Functional Genomics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End-User
7.3.4. Italy Functional Genomics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End-User
7.3.5. Spain Functional Genomics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End-User
8. Asia Pacific Functional Genomics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End-User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Functional Genomics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End-User
8.3.2. India Functional Genomics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End-User
8.3.3. Japan Functional Genomics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End-User
8.3.4. South Korea Functional Genomics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End-User
8.3.5. Australia Functional Genomics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End-User
9. Middle East & Africa Functional Genomics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End-User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Functional Genomics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End-User
9.3.2. UAE Functional Genomics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End-User
9.3.3. South Africa Functional Genomics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End-User
10. South America Functional Genomics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End-User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Functional Genomics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End-User
10.3.2. Colombia Functional Genomics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By End-User
10.3.3. Argentina Functional Genomics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
10.3.3.2.4. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Functional Genomics Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Agilent Technologies, Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Becton, Dickinson and Company
15.3. Bio-Rad Laboratories, Inc.
15.4. Danaher Corporation (Integrated DNA Technologies, Inc.)
